References
- Orban PC, Chui D, Marth JD. Tissue- and site-specific DNA recombination in transgenic mice. Proc Natl Acad Sci U S A. 1992;89:6861–6865.
- Stricklett PK, Nelson RD, Kohan DE. Site-specific recombination using an epitope tagged bacteriophage P1 Cre recombinase. Gene. 1998;215:415–423.
- Metzger D, Clifford J, Chiba H, et al. Conditional site-specific recombination in mammalian cells using a ligand-dependent chimeric Cre recombinase. Proc Natl Acad Sci U S A. 1995;92:6991–6995.
- Indra AK, Warot X, Brocard J, et al. Temporally-controlled site-specific mutagenesis in the basal layer of the epidermis: comparison of the recombinase activity of the tamoxifen-inducible Cre-ER(T) and Cre-ER(T2) recombinases. Nucleic Acids Res. 1999;27:4324–4327.
- Lee KY, Russell SJ, Ussar S, et al. Lessons on conditional gene targeting in mouse adipose tissue. Diabetes. 2013;62:864–874.
- Blüher M. Obesity: global epidemiology and pathogenesis. Nat Rev Endocrinol. 2019;15(288). DOI:10.1038/s41574-019-0176-8
- Mullican SE, Tomaru T, Gaddis CA, et al. A novel adipose-specific gene deletion model demonstrates potential pitfalls of existing methods. Mol Endocrinol. 2012;27:127–134.
- Jeffery E, Berry R, Church CD, et al. Characterization of Cre recombinase models for the study of adipose tissue. Adipocyte. 2014;3:206–211.
- Sassmann A, Offermanns S, Wettschureck N. Tamoxifen-inducible Cre-mediated recombination in adipocytes. Genesis (New York, N.Y.: 2000). 2010;48:618–625.
- Sakaguchi M, Fujisaka S, Cai W, et al. Adipocyte dynamics and reversible metabolic syndrome in mice with an inducible adipocyte-specific deletion of the insulin receptor. Cell Metab. 2017;25:448–462.
- Hesselbarth N, Pettinelli C, Gericke M, et al. Tamoxifen affects glucose and lipid metabolism parameters, causes browning of subcutaneous adipose tissue and transient body composition changes in C57BL/6NTac mice. Biochem Biophys Res Commun. 2015;464:724–729.
- Liu L, Zou P, Zheng L, et al. Tamoxifen reduces fat mass by boosting reactive oxygen species. Cell Death Dis. 2015;6:e1586.
- Ye R, Wang QA, Tao C, et al. Impact of tamoxifen on adipocyte lineage tracing: inducer of adipogenesis and prolonged nuclear translocation of Cre recombinase. Mol Metab. 2015;4:771–778.
- Gericke M, Weyer U, Braune J, et al. A method for long-term live imaging of tissue macrophages in adipose tissue explants. Am J Physiol Endocrinol Metab. 2015;308:E1023–33.
- Madisen L, Zwingman TA, Sunkin SM, et al. A robust and high-throughput Cre reporting and characterization system for the whole mouse brain. Nat Neurosci. 2010;13:133–140.
- Kristianto J, Johnson MG, Zastrow RK, et al. Spontaneous recombinase activity of Cre-ERT2 in vivo. Transgenic Res. 2017;26:411–417.
- Orthgiess J, Gericke M, Immig K, et al. Neurons exhibit Lyz2 promoter activity in vivo: implications for using LysM-Cre mice in myeloid cell research. Eur J Immunol. 2016;46:1529–1532.
- Goldmann T, Wieghofer, P, Jordão, MJC, et al. Origin, fate and dynamics of macrophages at CNS interfaces. Nat Immunol. 2016;17:797–805.